@Article{Lass2001,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="5",
number="5",
year="2001",
title="Radionuclide therapy of bone metastases",
abstract="Most patients with bone metastases experience painful symptoms. Systemic radioisotope therapy is an alternative to traditional hemibody radiation in cases of multiple, diffuse metastases. Usually given as a single i.v. slow-push infusion it gives a pain relief beginning after one to three weeks, with a mean duration up to several months, depending of the kind of a radioisotope applied. This paper reviews the role of unsealed source therapy with these bone-seeking radiopharmaceuticals in palliating pain and improving quality of life. Indications, contraindications and complications of this therapy, as well as cost-benefit aspects are discussed.",
author="Lass, Piotr",
pages="185--187",
url="https://www.termedia.pl/Radionuclide-therapy-of-bone-metastases,3,626,1,1.html"
}